Maricann Group Inc. Receives Their GMP Certification with the European Medicines Agency | CashCropToday
0 Shares 158 Views

Maricann Group Inc. Receives Their GMP Certification with the European Medicines Agency

April 30, 2018
158 Views

Maricann Group Inc. (CSE:MARI)(OTCQB:MRRCF) announced this morning that the company has received its Good Manufacturing Practice (GMP) certification from the European Medicines Agency.

The Maricann Group is a vertically integrated, public cannabis company located in Ontario, Canada. The company currently operates cultivation, extraction, formulation and distribution facilities in accordance with federal law in Canada.

The company started the difficult process of obtaining their GMP certification back in the Q4 of 2017. Health inspectors visited the Maricann Group’s facility in Langton, Ontario where the company is currently expanding their operations to house 942,000 sq. ft. of production and processing space.

Maricann is one of only 6 different medical marijuana producers in Canada that’s have obtained their GMP certification. By obtaining this, the Maricann Group qualifies to now export medicinal cannabis onto the continent of Europe.

Ben Ward, CEO of the company, gave this statement in the press release:

“EMA-GMP certification of our cultivation facility in Canada demonstrates further progress at Maricann. External validation of our operations provides comfort to our patients and consumers that we exceed industry standards. Our commitment to total quality, from origination to finished product is now certified.”

You may be interested

OTC Markets Group Welcomes TerrAscend Corp. to OTCQX
Market Watch
20 views
Market Watch
20 views

OTC Markets Group Welcomes TerrAscend Corp. to OTCQX

Jaelynn Offerman - October 22, 2018

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced TerrAscend Corp. (CSE: TER; OTCQX: TRSSF), a biopharmaceutical and wellness company that…

Pivot Pharmaceuticals Signs Agreement with Licorera Del Sur Subsidiary Cartagena Inc. To Create Joint Venture To Commercialize Cannabis-Infused Non-Alcoholic Beverages
Global
11 views
Global
11 views

Pivot Pharmaceuticals Signs Agreement with Licorera Del Sur Subsidiary Cartagena Inc. To Create Joint Venture To Commercialize Cannabis-Infused Non-Alcoholic Beverages

Jaelynn Offerman - October 22, 2018

Pivot Pharmaceuticals, Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Letter of Intent to create a Joint Venture…

MedMen to Sell Three Retail Locations to Treehouse Real Estate for $12.5M
Market Watch
44 views
Market Watch
44 views

MedMen to Sell Three Retail Locations to Treehouse Real Estate for $12.5M

Editor - October 19, 2018

MedMen Enterprises Inc. (CSE: MMEN) (OTCQB: MMNFF) announced this week that the company has agreed to sell three seperate cannabis retail locations to Treehouse Real Estate Investment…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: